269 related articles for article (PubMed ID: 15102599)
41. Open reading frame 73 is required for herpesvirus saimiri A11-S4 episomal persistence.
Calderwood M; White RE; Griffiths RA; Whitehouse A
J Gen Virol; 2005 Oct; 86(Pt 10):2703-2708. PubMed ID: 16186223
[TBL] [Abstract][Full Text] [Related]
42. Infectious delivery of 120-kilobase genomic DNA by an epstein-barr virus amplicon vector.
White RE; Wade-Martins R; James MR
Mol Ther; 2002 Apr; 5(4):427-35. PubMed ID: 11945070
[TBL] [Abstract][Full Text] [Related]
43. The Herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32.
Hall KT; Giles MS; Calderwood MA; Goodwin DJ; Matthews DA; Whitehouse A
J Virol; 2002 Nov; 76(22):11612-22. PubMed ID: 12388722
[TBL] [Abstract][Full Text] [Related]
44. Rhadinovirus vector-derived human telomerase reverse transcriptase expression in primary T cells.
Toptan T; Ensser A; Fickenscher H
Gene Ther; 2010 May; 17(5):653-61. PubMed ID: 20164858
[TBL] [Abstract][Full Text] [Related]
45. Viral vectors for gene therapy.
Robbins PD; Ghivizzani SC
Pharmacol Ther; 1998 Oct; 80(1):35-47. PubMed ID: 9804053
[TBL] [Abstract][Full Text] [Related]
46. Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications.
Burton EA; Fink DJ; Glorioso JC
Curr Opin Mol Ther; 2005 Aug; 7(4):326-36. PubMed ID: 16121698
[TBL] [Abstract][Full Text] [Related]
47. Persistence of selectable herpesvirus saimiri in various human haematopoietic and epithelial cell lines.
Simmer B; Alt M; Buckreus I; Berthold S; Fleckenstein B; Platzer E; Grassmann R
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1953-8. PubMed ID: 1651988
[TBL] [Abstract][Full Text] [Related]
48. Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration-deficient retroviral vectors.
Schott JW; Jaeschke NM; Hoffmann D; Maetzig T; Ballmaier M; Godinho T; Cathomen T; Schambach A
Cytometry A; 2015 May; 87(5):405-18. PubMed ID: 25728583
[TBL] [Abstract][Full Text] [Related]
49. Building mosaics of therapeutic plasmid gene vectors.
Tolmachov OE
Curr Gene Ther; 2011 Dec; 11(6):466-78. PubMed ID: 22023476
[TBL] [Abstract][Full Text] [Related]
50. Developing extrachromosomal gene expression vector technologies: an overview.
Wade-Martins R
Methods Mol Biol; 2011; 738():1-17. PubMed ID: 21431716
[TBL] [Abstract][Full Text] [Related]
51. Adenovirus vectors for renal-targeted gene delivery.
Appledorn DM; Seregin S; Amalfitano A
Contrib Nephrol; 2008; 159():47-62. PubMed ID: 18391584
[TBL] [Abstract][Full Text] [Related]
52. Foamy virus vectors.
Mergia A; Heinkelein M
Curr Top Microbiol Immunol; 2003; 277():131-59. PubMed ID: 12908771
[TBL] [Abstract][Full Text] [Related]
53. Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy.
Mulia GE; Picanço-Castro V; Stavrou EF; Athanassiadou A; Figueiredo ML
Hum Gene Ther; 2021 Oct; 32(19-20):1076-1095. PubMed ID: 34348480
[TBL] [Abstract][Full Text] [Related]
54. Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.
Han F; Miyagawa Y; Verlengia G; Ingusci S; Soukupova M; Simonato M; Glorioso JC; Cohen JB
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950408
[TBL] [Abstract][Full Text] [Related]
55. Self-Repairing Herpesvirus Saimiri Deletion Variants.
Heyn I; Bremer L; Zingler P; Fickenscher H
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891505
[TBL] [Abstract][Full Text] [Related]
56. Gene delivery and gene therapy with herpes simplex virus-based vectors.
Latchman DS
Gene; 2001 Feb; 264(1):1-9. PubMed ID: 11245972
[TBL] [Abstract][Full Text] [Related]
57. A pair of selectable herpesvirus vectors for simultaneous gene expression in human lymphoid cells.
Alt M; Fleckenstein B; Grassmann R
Gene; 1991 Jun; 102(2):265-9. PubMed ID: 1651885
[TBL] [Abstract][Full Text] [Related]
58. Engineered Non-Viral Gene Vectors for Combination Cancer Therapy: A Review.
Zheng Q; Lin D; Lei L; Li X; Shi S
J Biomed Nanotechnol; 2017 Dec; 13(12):1565-1580. PubMed ID: 29490748
[TBL] [Abstract][Full Text] [Related]
59. Multiple applications for replication-defective herpes simplex virus vectors.
Burton EA; Wechuck JB; Wendell SK; Goins WF; Fink DJ; Glorioso JC
Stem Cells; 2001; 19(5):358-77. PubMed ID: 11553845
[TBL] [Abstract][Full Text] [Related]
60. Design and in vitro characterization of a single regulatory module for efficient control of gene expression in both plasmid DNA and a self-inactivating lentiviral vector.
Ogueta SB; Yao F; Marasco WA
Mol Med; 2001 Aug; 7(8):569-79. PubMed ID: 11591893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
